CompletedPhase 4

Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women

Saudi Arabia250 participantsStarted 2013-07

Plain-language summary

Reducing the length of labor is a highly desirable goal of intrapartum care, both from a perspective of maternal and fetal well-being , and for the providers of the birth services. Avoiding a long , protracted labor entails shorter exposure to pain anxiety and stress and would translate into a major improvement in maternal satisfaction with the child birth experience. The purpose of this study is to determine the effectiveness of metoclopramide for reducing the duration of spontaneous labor among nulliparous women managed according to a standard intrapartum protocol.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primigravida * Singleton pregnancy * Term gestation i.e. 37- 42 weeks * Sure reliable dates * Vertex presentation, occipitoanterior position * Spontaneous onset of labor * Regular uterine contractions at every 5 min ,each lasting for 20 sec * Cervical dilatation of 3-5cm * With or without rupture of membranes * No evidence of maternal or fetal distress Exclusion Criteria: * Mal-presentations * Mal-positions * Multifetal pregnancy * Cephalopelvic disproportion * history of cervical surgery or injury * Hypersensitivity to metoclopramide

What they're measuring

Cervical dilatation rate

Timeframe: 6 hours

Trial details

NCT IDNCT01937234

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-07

View on ClinicalTrials.gov More Prolonged First Stage of Labor trials